查找临床试验
已按「肺癌」检索，对应国际通用词 lung cancer
共找到 12 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 09:55，每 5 分钟自动同步IMMUNO-LUNG : Identification of Biomarkers and Therapeutic Targets for Pulmonary Immunotherapy
France
年龄 18 Years – 不限
Institut Paoli-Calmettes
Current Practice of Ventilation Strategies in Children Undergoing General Anesthesia
Australia、Italy、Netherlands、Switzerland
年龄 不限 – 16 Years
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Pembrolizumab for Advanced NSCLC and PS 2-3
United States
年龄 18 Years – 不限
Icahn School of Medicine at Mount Sinai
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
United States、Puerto Rico
年龄 18 Years – 不限
Terremoto Biosciences Inc.
Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma
Belgium
年龄 18 Years – 不限
University Hospital, Antwerp
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
United States、Japan
年龄 18 Years – 不限
Astellas Pharma Global Development, Inc.
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
United States
年龄 18 Years – 不限
Regeneron Pharmaceuticals
Exercise and Nutrition on Early-stage NSCLC Outcomes: the STARLighT Study
Italy
年龄 18 Years – 不限
Universita di Verona
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
United States、China、Israel、Japan、Puerto Rico 等 7 国
年龄 18 Years – 不限
AbbVie
Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer
Canada
年龄 18 Years – 不限
University Health Network, Toronto
Comprehensive Outcomes for After Cancer Health
United States
年龄 18 Years – 不限
Pack Health
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
United States
年龄 18 Years – 不限
OHSU Knight Cancer Institute